Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2009-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/14/4/1342/ |
id |
doaj-7358a25f60b841a0b2ec110d2483461e |
---|---|
record_format |
Article |
spelling |
doaj-7358a25f60b841a0b2ec110d2483461e2020-11-24T20:55:15ZengMDPI AGMolecules1420-30492009-03-011441342135210.3390/molecules14041342Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I ActivityJau-Lang HwangChiao-En ChenChun-Mao LinChi-Ming LeeAgnes L.-F. ChanWen-Shin ChangLi-Min ChenEvodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0~10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2% in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex. http://www.mdpi.com/1420-3049/14/4/1342/EvodiamineTopoisomeraseCovalent complex |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jau-Lang Hwang Chiao-En Chen Chun-Mao Lin Chi-Ming Lee Agnes L.-F. Chan Wen-Shin Chang Li-Min Chen |
spellingShingle |
Jau-Lang Hwang Chiao-En Chen Chun-Mao Lin Chi-Ming Lee Agnes L.-F. Chan Wen-Shin Chang Li-Min Chen Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity Molecules Evodiamine Topoisomerase Covalent complex |
author_facet |
Jau-Lang Hwang Chiao-En Chen Chun-Mao Lin Chi-Ming Lee Agnes L.-F. Chan Wen-Shin Chang Li-Min Chen |
author_sort |
Jau-Lang Hwang |
title |
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
title_short |
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
title_full |
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
title_fullStr |
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
title_full_unstemmed |
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity |
title_sort |
evodiamine stabilizes topoisomerase i-dna cleavable complex to inhibit topoisomerase i activity |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2009-03-01 |
description |
Evodiamine (EVO), an alkaloidal compound isolated from Evodia rutaecarpa (Juss.), has been reported to affect many physiological functions. Topoisomerase inhibitors have been developed in a variety of clinical applications. In the present study, we report the topoisomerase I (TopI) inhibitory activity of EVO, which may have properties that lead to improved therapeutic benefits. EVO is able to inhibit supercoiled plasmid DNA relaxation catalyzed by TopI. Upon treatment 0~10 μM EVO TopI was depleted in MCF-7 breast cancer cells in a concentration-dependent and time-dependent manner in 0~120 min. A K-SDS precipitation assay was performed to measure the extent of Top I-trapped chromosomal DNA. The ability of EVO to cause the formation of a TopI-DNA complex increased in a concentration-dependent manner, in that the DNA trapped increased by 24.2% in cells treated with 30 μM. The results suggest that EVO inhibits TopI by stabilizing the enzyme and DNA covalent complex. |
topic |
Evodiamine Topoisomerase Covalent complex |
url |
http://www.mdpi.com/1420-3049/14/4/1342/ |
work_keys_str_mv |
AT jaulanghwang evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT chiaoenchen evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT chunmaolin evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT chiminglee evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT agneslfchan evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT wenshinchang evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity AT liminchen evodiaminestabilizestopoisomeraseidnacleavablecomplextoinhibittopoisomeraseiactivity |
_version_ |
1716792041139077120 |